Buy or sell Huma Therapeutics stock pre IPO via an EquityZen fund
Huma Therapeutics Stock
Huma provides a digital health platform used for predictive care and research.
About Huma Therapeutics Stock
Huma is a global health technology company that provides a modular platform to support digital 'hospitals at home' across different disease areas. Its platform combines predictive algorithms, digital biomarkers, and real-world data to advance proactive, predictive care and research. The company was founded in 2011 and is headquartered in London, England.
Co-founder & CEO
Co-founder and Executive Director
SVP Business Development, US
Life Sciences Partnerships Manager
Product Design Lead
Head of Healthcare
Talent Partner - Technology and Product
Senior Vice President
Rt Hon Alan Milburn
TechCrunch - Apr, 16 2020